Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 05, 2015 8:50 PM ET

Pharmaceuticals

Company Overview of Zoetis Inc.

Company Overview

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines and vaccines for livestock and companion animals worldwide. The company operates through four segments: the United States; Europe/Africa/Middle East; Canada/Latin America; and Asia/Pacific. It offers anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; vaccines that are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; and parasiticides that prevent or eliminate external and internal parasites, such as fleas, ticks, and worms. The company also provides m...

100 Campus Drive

Florham Park, NJ 07932

United States

Founded in 1952

10,000 Employees

Phone:

973-822-7000

Key Executives for Zoetis Inc.

Chief Executive Officer and Director
Age: 63
Total Annual Compensation: $1.1M
Group President and Executive Vice President
Age: 42
Total Annual Compensation: $620.4K
Chief Financial Officer and Executive Vice President
Age: 58
Total Annual Compensation: $207.6K
Executive Vice President and President of U.S. Operations
Age: 47
Total Annual Compensation: $451.4K
President of Research & Development and Executive Vice President
Age: 53
Total Annual Compensation: $451.4K
Compensation as of Fiscal Year 2014.

Zoetis Inc. Key Developments

Zoetis Inc. Appoints Paul M. Bisaro to Board of Directors, Effective May 1, 2015

Zoetis Inc. announced that its Board of Directors has appointed Paul M. Bisaro, Executive Chairman of Actavis plc, to the company’s Board of Directors. Mr. Bisaro’s term will begin immediately following the company’s 2015 Annual Meeting of Shareholders, which is scheduled for May 1, 2015. With the addition of Mr. Bisaro, the Zoetis Board will expand to 11 directors, and he will serve on the Compensation Committee. He previously served as President, CEO and Chairman of the Board of Actavis. Prior to joining Actavis, he was President and Chief Operating Officer of Barr Pharmaceuticals Inc. He also served as General Counsel at Barr and held various additional roles, including Senior Vice President of Strategic Business Development. Prior to joining Barr, Mr. Bisaro was associated with the law firm Winston & Strawn and a predecessor firm, Bishop, Cook, Purcell and Reynolds. He also served as a Senior Consultant with Arthur Andersen & Co.

Zoetis Inc. to Report Q1, 2015 Results on May 05, 2015

Zoetis Inc. announced that they will report Q1, 2015 results at 8:30 AM, US Eastern Standard Time on May 05, 2015

Zoetis Inc., Q1 2015 Earnings Call, May 05, 2015

Zoetis Inc., Q1 2015 Earnings Call, May 05, 2015

Similar Private Companies By Industry

Company Name Region
FunGuys LLC United States
Fillco, Inc. United States
LifeTime Pharmaceuticals United States
Equine Nutraceuticals Inc. United States
Kremers Urban, LLC United States

Recent Private Companies Transactions

Type
Date
Target
Buyback
November 18, 2014
--
Merger/Acquisition
November 17, 2014
Abbott Animal Health, Animal Health Assets
Merger/Acquisition
November 11, 2014
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Zoetis Inc., please visit www.zoetis.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.